- Home
- OUST vs STRO Comparison
OUST vs STRO Comparison
Compare OUST & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- STRO
- Stock Information
- Founded
- OUST 2015
- STRO 2003
- Country
- OUST United States
- STRO United States
- Employees
- OUST N/A
- STRO N/A
- Industry
- OUST Industrial Machinery/Components
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OUST Technology
- STRO Health Care
- Exchange
- OUST Nasdaq
- STRO Nasdaq
- Market Cap
- OUST 491.7M
- STRO 172.8M
- IPO Year
- OUST N/A
- STRO 2018
- Fundamental
- Price
- OUST $12.35
- STRO $1.93
- Analyst Decision
- OUST Buy
- STRO Strong Buy
- Analyst Count
- OUST 6
- STRO 7
- Target Price
- OUST $12.83
- STRO $12.14
- AVG Volume (30 Days)
- OUST 1.8M
- STRO 1.3M
- Earning Date
- OUST 11-07-2024
- STRO 11-13-2024
- Dividend Yield
- OUST N/A
- STRO N/A
- EPS Growth
- OUST N/A
- STRO N/A
- EPS
- OUST N/A
- STRO N/A
- Revenue
- OUST $105,453,000.00
- STRO $160,955,000.00
- Revenue This Year
- OUST $35.92
- STRO N/A
- Revenue Next Year
- OUST $30.97
- STRO N/A
- P/E Ratio
- OUST N/A
- STRO N/A
- Revenue Growth
- OUST 51.14
- STRO 230.90
- 52 Week Low
- OUST $4.65
- STRO $1.70
- 52 Week High
- OUST $16.88
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- OUST 62.23
- STRO 34.06
- Support Level
- OUST $11.48
- STRO $1.80
- Resistance Level
- OUST $13.93
- STRO $2.01
- Average True Range (ATR)
- OUST 1.40
- STRO 0.16
- MACD
- OUST 0.12
- STRO 0.02
- Stochastic Oscillator
- OUST 68.84
- STRO 29.49
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.